image

The best stocks to buy since 1993

Latest issue now available

Patientline - Finance Director buys shares

July 2004

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • PTL
  • Price:
  • 128.5p
Results for the year to 31 March  showed sales increase dramatically from £22m to £37.2m as a further 21,000 terminals went live to take the number to 55,700 in 120 hospitals. This compares to the 44,000 terminals in 94 hospitals last September.  The depreciation charge was £17.2m in 2004 (2003:£10m) but this will continue to rise as Patientline spent £43m on its UK and Dutch rollout. This made its results look much worse than they were. Pretax loss lifted from £7.2m to £8.2m (but demonstrating the strength of Patientline's cash generation EBITDA tripled to £9m). Since the year end, the number of contracted / selected UK hospitals has risen to 191 which makes it the dominan ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe